首页 > 最新文献

Israel Journal of Health Policy Research最新文献

英文 中文
The importance of vision care for displaced populations: lessons from Israeli evacuees. 为流离失所者提供视力保健的重要性:以色列疏散人员的经验教训。
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-06-06 DOI: 10.1186/s13584-024-00615-x
Hadas Ben-Eli, Itay Chowers, Ariela Gordon-Shaag

Background: This study explores vision care priorities and coping mechanisms for Israeli evacuees and following the October 7th, 2023, attack by Hamas, which displaced 150,000 individuals, with about 15,000 being evacuated to the Dead Sea area. Faced with minimal health care infrastructure in the Dead Sea area and often lacking personal belongings, including eyeglasses and ocular medicine, these evacuees confronted significant vision care challenges. This context sets the stage for investigating the emergency vision care needs and solutions for populations affected by conflict and displacement.

Methods: In response to this crisis, a consortium led by Hadassah Academic College's Department of Optometry and the Dept. of Ophthalmology at Hadassah Medical Center established ophthalmic clinics in the Dead Sea region. These clinics offered comprehensive vision care services, including refractive and vision examinations, ophthalmological assessments, ocular imaging, and provision of free glasses. The setup included multiple stations for different vision tests, staffed by an interdisciplinary team of professionals. The study analyzes the effectiveness of these clinics, patient flow challenges, and the psychological impact of vision care in a crisis setting.

Results: Approximately 800 evacuees received examinations, with around 700 pairs of glasses distributed. Notable cases included emergency referrals for serious conditions and instances where glasses served as psychological support. The operation highlighted the necessity of vision care during crises and its potential psychological and social implications. The clinics successfully provided immediate vision care, but challenges in patient flow and insufficient electronic medical record integration were noted. The experience underscores the importance of prepared eye care interventions in crises. Recommendations for health policy decision-makers include establishing a national emergency vision care network, developing standardized treatment protocols, training local health workers, and raising public awareness about eye health in emergencies.

Conclusions: The consortium's effort in providing urgent vision care to evacuees from the Hamas attack on Israel demonstrates the critical role of rapid, organized eye care in crisis situations. Vision care, along with hearing and mobility, is often overlooked during evacuations but is vital for the well-being and survival of evacuees, especially under trying circumstances. This project serves as a model for future humanitarian interventions, emphasizing the importance of addressing overlooked healthcare issues once the immediate crisis has passed, and the need for strategic planning in health care policy for similar emergency scenarios.

背景:2023 年 10 月 7 日,哈马斯发动袭击,造成 15 万人流离失所,其中约 1.5 万人被疏散到死海地区。面对死海地区极少的医疗基础设施,以及通常缺乏包括眼镜和眼科药物在内的个人物品,这些撤离者面临着巨大的视力保健挑战。这一背景为研究受冲突和流离失所影响人群的紧急视力保健需求和解决方案提供了基础:为了应对这场危机,哈大沙学术学院验光系和哈大沙医疗中心眼科部领导的一个联合体在死海地区建立了眼科诊所。这些诊所提供全面的视力保健服务,包括屈光和视力检查、眼科评估、眼部成像和提供免费眼镜。诊所的设置包括多个不同视力检测站,由跨学科的专业团队提供服务。研究分析了这些诊所的有效性、病人流量挑战以及危机环境下视力保健的心理影响:结果:约有 800 名疏散人员接受了检查,并分发了约 700 副眼镜。值得注意的案例包括严重疾病的紧急转诊和眼镜作为心理支持的情况。这次行动强调了危机期间视力保健的必要性及其潜在的心理和社会影响。诊所成功地提供了即时的视力保健服务,但也注意到在病人流动和电子病历整合方面存在的挑战。这次经验强调了在危机中进行有准备的视力保健干预的重要性。对卫生政策决策者的建议包括建立全国紧急视力保健网络、制定标准化治疗方案、培训当地卫生工作者以及提高公众对紧急情况下眼睛健康的认识:联合体为从哈马斯袭击以色列事件中撤离的人员提供紧急视力保健服务的努力表明,快速、有组织的眼保健服务在危机情况下发挥着至关重要的作用。视力保健与听力和行动能力一样,在撤离过程中经常被忽视,但对于撤离人员的福祉和生存却至关重要,尤其是在艰难的情况下。该项目为未来的人道主义干预行动树立了典范,强调了在紧急危机过去后解决被忽视的医疗保健问题的重要性,以及为类似紧急情况制定医疗保健政策战略规划的必要性。
{"title":"The importance of vision care for displaced populations: lessons from Israeli evacuees.","authors":"Hadas Ben-Eli, Itay Chowers, Ariela Gordon-Shaag","doi":"10.1186/s13584-024-00615-x","DOIUrl":"10.1186/s13584-024-00615-x","url":null,"abstract":"<p><strong>Background: </strong>This study explores vision care priorities and coping mechanisms for Israeli evacuees and following the October 7th, 2023, attack by Hamas, which displaced 150,000 individuals, with about 15,000 being evacuated to the Dead Sea area. Faced with minimal health care infrastructure in the Dead Sea area and often lacking personal belongings, including eyeglasses and ocular medicine, these evacuees confronted significant vision care challenges. This context sets the stage for investigating the emergency vision care needs and solutions for populations affected by conflict and displacement.</p><p><strong>Methods: </strong>In response to this crisis, a consortium led by Hadassah Academic College's Department of Optometry and the Dept. of Ophthalmology at Hadassah Medical Center established ophthalmic clinics in the Dead Sea region. These clinics offered comprehensive vision care services, including refractive and vision examinations, ophthalmological assessments, ocular imaging, and provision of free glasses. The setup included multiple stations for different vision tests, staffed by an interdisciplinary team of professionals. The study analyzes the effectiveness of these clinics, patient flow challenges, and the psychological impact of vision care in a crisis setting.</p><p><strong>Results: </strong>Approximately 800 evacuees received examinations, with around 700 pairs of glasses distributed. Notable cases included emergency referrals for serious conditions and instances where glasses served as psychological support. The operation highlighted the necessity of vision care during crises and its potential psychological and social implications. The clinics successfully provided immediate vision care, but challenges in patient flow and insufficient electronic medical record integration were noted. The experience underscores the importance of prepared eye care interventions in crises. Recommendations for health policy decision-makers include establishing a national emergency vision care network, developing standardized treatment protocols, training local health workers, and raising public awareness about eye health in emergencies.</p><p><strong>Conclusions: </strong>The consortium's effort in providing urgent vision care to evacuees from the Hamas attack on Israel demonstrates the critical role of rapid, organized eye care in crisis situations. Vision care, along with hearing and mobility, is often overlooked during evacuations but is vital for the well-being and survival of evacuees, especially under trying circumstances. This project serves as a model for future humanitarian interventions, emphasizing the importance of addressing overlooked healthcare issues once the immediate crisis has passed, and the need for strategic planning in health care policy for similar emergency scenarios.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"13 1","pages":"29"},"PeriodicalIF":4.5,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11157822/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141285000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timely care for age-related macular degeneration: a qualitative study among retina specialists in Israel. 老年黄斑变性的及时治疗:对以色列视网膜专家的定性研究。
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-06-04 DOI: 10.1186/s13584-024-00616-w
Vicki Myers, Osnat Luxenburg, Rachel Wilf-Miron, Hani Levkovitch Verbin

Background: Age-related macular degeneration (AMD) affects quality of life and independence, and its incidence and prevalence are increasing due to ageing of the population. Access to effective timely treatment can improve vision and reduce incidence of blindness. This study aimed to explore the perspectives of ophthalmologists in the Israeli public healthcare system regarding timely treatment of AMD patients.

Methods: Qualitative semi-structured interviews were conducted in 2020-2021 with 22 senior ophthalmologists, from 10 general hospitals and from two HMOs, representing different geographic regions. All interviewees specialize in retinal diseases and work with AMD patients. Interviews discussed patient pathways involved in the diagnosis and treatment of AMD, access to care, and obstacles to timely care. Thematic analysis was conducted.

Results: Based on the interviews, we describe the usual referral and treatment pathways. Themes included regional disparities, long wait times in some areas, a lack of retina specialists, differences in referral pathways, inappropriate use of emergency department to obtain timely treatment, and second-line treatment not fully covered by insurance, most affecting the weakest segments of the population.

Conclusions: Loss of vision incurs high health and societal costs. In the context of insufficient medical manpower in Israel, the healthcare system will need to assess future resources to cope with accumulating burden of AMD cases over time in an ageing population. Precise referral information, and simultaneous referral to imaging and retinal clinics, may minimize delays in treatment. Awareness of AMD symptoms and the importance of early intervention could be highlighted by campaigns, particularly among high-risk groups.

Highlights: • Interviews with hospital-based and community ophthalmologists showed regional disparities in AMD treatment, with long wait times and a lack of retina specialists in some areas. • Differences in referral pathways, inappropriate use of emergency department to obtain timely treatment, and second line treatment not fully covered by insurance were highlighted. • The healthcare system will need to assess future resources to cope with accumulating burden of AMD cases over time in an ageing population • Precise referral information, and simultaneous referral to imaging and retinal clinics, may minimize delays in treatment. • Awareness of AMD symptoms and the importance of early intervention should be emphasized in high-risk groups.

背景:年龄相关性黄斑变性(AMD)影响生活质量和独立性,其发病率和流行率因人口老龄化而不断上升。及时获得有效治疗可以改善视力,降低失明率。本研究旨在探讨以色列公共医疗系统中的眼科医生对及时治疗 AMD 患者的看法:2020-2021 年,我们对来自 10 家综合医院和两家 HMO(代表不同地区)的 22 名资深眼科医生进行了半结构式定性访谈。所有受访者均擅长视网膜疾病,并为 AMD 患者提供服务。访谈讨论了诊断和治疗老年性视网膜病变所涉及的患者路径、获得护理的途径以及及时护理的障碍。我们进行了专题分析:根据访谈,我们描述了通常的转诊和治疗途径。主题包括地区差异、某些地区等待时间过长、缺乏视网膜专科医生、转诊途径存在差异、为获得及时治疗而不适当地使用急诊科、二线治疗未完全纳入保险范围等,这些问题对人口中最弱势的群体影响最大:结论:视力丧失会造成高昂的医疗和社会成本。在以色列医护人员不足的情况下,医疗系统需要评估未来的资源,以应对随着时间推移人口老龄化而不断增加的 AMD 病例负担。准确的转诊信息以及同时转诊至影像和视网膜诊所可最大限度地减少治疗延误。可以通过宣传活动,特别是针对高危人群的宣传活动,提高人们对老年性视网膜病变症状和早期干预重要性的认识:- 对医院和社区眼科医生的访谈显示,AMD 的治疗存在地区差异,有些地区的等待时间很长,而且缺乏视网膜专科医生。- 转诊途径的差异、为获得及时治疗而不适当地使用急诊科以及二线治疗未完全纳入保险范围等问题也得到了强调。- 医疗系统需要评估未来的资源,以应对随着人口老龄化而不断累积的老年性视网膜病变病例--准确的转诊信息以及同时转诊至影像科和视网膜科,可最大限度地减少治疗延误。- 应在高危人群中强调对老年性视网膜病变症状的认识和早期干预的重要性。
{"title":"Timely care for age-related macular degeneration: a qualitative study among retina specialists in Israel.","authors":"Vicki Myers, Osnat Luxenburg, Rachel Wilf-Miron, Hani Levkovitch Verbin","doi":"10.1186/s13584-024-00616-w","DOIUrl":"10.1186/s13584-024-00616-w","url":null,"abstract":"<p><strong>Background: </strong>Age-related macular degeneration (AMD) affects quality of life and independence, and its incidence and prevalence are increasing due to ageing of the population. Access to effective timely treatment can improve vision and reduce incidence of blindness. This study aimed to explore the perspectives of ophthalmologists in the Israeli public healthcare system regarding timely treatment of AMD patients.</p><p><strong>Methods: </strong>Qualitative semi-structured interviews were conducted in 2020-2021 with 22 senior ophthalmologists, from 10 general hospitals and from two HMOs, representing different geographic regions. All interviewees specialize in retinal diseases and work with AMD patients. Interviews discussed patient pathways involved in the diagnosis and treatment of AMD, access to care, and obstacles to timely care. Thematic analysis was conducted.</p><p><strong>Results: </strong>Based on the interviews, we describe the usual referral and treatment pathways. Themes included regional disparities, long wait times in some areas, a lack of retina specialists, differences in referral pathways, inappropriate use of emergency department to obtain timely treatment, and second-line treatment not fully covered by insurance, most affecting the weakest segments of the population.</p><p><strong>Conclusions: </strong>Loss of vision incurs high health and societal costs. In the context of insufficient medical manpower in Israel, the healthcare system will need to assess future resources to cope with accumulating burden of AMD cases over time in an ageing population. Precise referral information, and simultaneous referral to imaging and retinal clinics, may minimize delays in treatment. Awareness of AMD symptoms and the importance of early intervention could be highlighted by campaigns, particularly among high-risk groups.</p><p><strong>Highlights: </strong>• Interviews with hospital-based and community ophthalmologists showed regional disparities in AMD treatment, with long wait times and a lack of retina specialists in some areas. • Differences in referral pathways, inappropriate use of emergency department to obtain timely treatment, and second line treatment not fully covered by insurance were highlighted. • The healthcare system will need to assess future resources to cope with accumulating burden of AMD cases over time in an ageing population • Precise referral information, and simultaneous referral to imaging and retinal clinics, may minimize delays in treatment. • Awareness of AMD symptoms and the importance of early intervention should be emphasized in high-risk groups.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"13 1","pages":"28"},"PeriodicalIF":4.5,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11151479/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141248924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demographic and injury trends for car crash casualties hospitalized in Level I Trauma centers over two decades: data from the National Trauma Registry. 二十年来在一级创伤中心住院的车祸伤员的人口统计和受伤趋势:来自国家创伤登记处的数据。
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-05-29 DOI: 10.1186/s13584-024-00613-z
Sharon Goldman, Irit Cohen-Manheim, Irina Radomislensky, Bella Savitsky, Moran Bodas

Background: During the past two decades, there have been many changes in automotive and medical technologies, road infrastructure, trauma systems, and demographic changes which may have influenced injury outcomes. The aim of this study was to examine injury trends among traffic casualties, specifically private car occupants, hospitalized in Level I Trauma Centers (TC).

Methods: A retrospective cohort study was performed based on data from the Israel National Trauma Registry. The data included occupants of private cars hospitalized in all six Level I TC due to a traffic collision related injury between January 1, 1998 and December 31, 2019. Demographic, injury and hospitalization characteristics and in-hospital mortality were analyzed. Chi-squared (X2) test, multivariable logistic regression models and Spearman's rank correlation were used to analyze injury data and trends.

Results: During the study period, 21,173 private car occupants (14,078 drivers, 4,527 front passengers, and 2,568 rear passengers) were hospitalized due to a traffic crash. The percentage of females hospitalized due to a car crash increased from 37.7% in 1998 to 53.7% in 2019. Over a twofold increase in hospitalizations among older adult drivers (ages 65+) was observed, from 6.5% in 1998 to 15.7% in 2018 and 12.6% in 2019. While no increase was observed for severe traumatic brain injury, a statistically significant increase in severe abdominal and thoracic injuries was observed among the non-Jewish population along with a constant decrease in in-hospital mortality.

Conclusions: This study provides interesting findings regarding injury and demographic trends among car occupants during the past two decades. Mortality among private car occupant casualties decreased during the study period, however an increase in serious abdominal and thoracic injuries was identified. The results should be used to design and implement policies and interventions for reducing injury and disability among car occupants.

背景:在过去的二十年中,汽车和医疗技术、道路基础设施、创伤系统以及人口结构的变化都发生了许多变化,这些变化可能会对伤害结果产生影响。本研究旨在探讨在一级创伤中心(TC)住院治疗的交通事故伤员(尤其是私家车乘员)的受伤趋势:方法:根据以色列国家创伤登记处的数据进行了一项回顾性队列研究。数据包括 1998 年 1 月 1 日至 2019 年 12 月 31 日期间因交通碰撞相关伤害而在所有六个一级创伤中心住院治疗的私家车乘员。对人口统计学、受伤和住院特征以及住院死亡率进行了分析。采用卡方检验(X2)、多变量逻辑回归模型和斯皮尔曼等级相关性分析受伤数据和趋势:在研究期间,21,173 名私家车乘客(14,078 名司机、4,527 名前排乘客和 2,568 名后排乘客)因交通事故住院。因车祸住院的女性比例从 1998 年的 37.7% 上升到 2019 年的 53.7%。老年驾驶员(65 岁以上)的住院率增加了两倍多,从 1998 年的 6.5% 增加到 2018 年的 15.7% 和 2019 年的 12.6%。虽然没有观察到严重脑外伤的增加,但在非犹太人口中观察到严重腹部和胸部损伤有统计学意义的显著增加,同时院内死亡率持续下降:这项研究提供了有关过去 20 年间汽车乘客受伤情况和人口趋势的有趣发现。在研究期间,私家车乘员的死亡率有所下降,但发现腹部和胸部严重受伤的人数有所增加。研究结果应用于设计和实施减少汽车乘客受伤和残疾的政策和干预措施。
{"title":"Demographic and injury trends for car crash casualties hospitalized in Level I Trauma centers over two decades: data from the National Trauma Registry.","authors":"Sharon Goldman, Irit Cohen-Manheim, Irina Radomislensky, Bella Savitsky, Moran Bodas","doi":"10.1186/s13584-024-00613-z","DOIUrl":"10.1186/s13584-024-00613-z","url":null,"abstract":"<p><strong>Background: </strong>During the past two decades, there have been many changes in automotive and medical technologies, road infrastructure, trauma systems, and demographic changes which may have influenced injury outcomes. The aim of this study was to examine injury trends among traffic casualties, specifically private car occupants, hospitalized in Level I Trauma Centers (TC).</p><p><strong>Methods: </strong>A retrospective cohort study was performed based on data from the Israel National Trauma Registry. The data included occupants of private cars hospitalized in all six Level I TC due to a traffic collision related injury between January 1, 1998 and December 31, 2019. Demographic, injury and hospitalization characteristics and in-hospital mortality were analyzed. Chi-squared (X<sup>2</sup>) test, multivariable logistic regression models and Spearman's rank correlation were used to analyze injury data and trends.</p><p><strong>Results: </strong>During the study period, 21,173 private car occupants (14,078 drivers, 4,527 front passengers, and 2,568 rear passengers) were hospitalized due to a traffic crash. The percentage of females hospitalized due to a car crash increased from 37.7% in 1998 to 53.7% in 2019. Over a twofold increase in hospitalizations among older adult drivers (ages 65+) was observed, from 6.5% in 1998 to 15.7% in 2018 and 12.6% in 2019. While no increase was observed for severe traumatic brain injury, a statistically significant increase in severe abdominal and thoracic injuries was observed among the non-Jewish population along with a constant decrease in in-hospital mortality.</p><p><strong>Conclusions: </strong>This study provides interesting findings regarding injury and demographic trends among car occupants during the past two decades. Mortality among private car occupant casualties decreased during the study period, however an increase in serious abdominal and thoracic injuries was identified. The results should be used to design and implement policies and interventions for reducing injury and disability among car occupants.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"13 1","pages":"27"},"PeriodicalIF":4.5,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11135010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141176481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: The Hamas massacre of Oct 7, 2023, and its aftermath, medical crimes, and the Lancet commission report on medicine, Nazism, and the Holocaust. 更正:2023 年 10 月 7 日哈马斯大屠杀及其后果、医疗犯罪以及柳叶刀委员会关于医学、纳粹主义和大屠杀的报告。
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-05-07 DOI: 10.1186/s13584-024-00610-2
Shmuel P Reis, Hedy S Wald
{"title":"Correction to: The Hamas massacre of Oct 7, 2023, and its aftermath, medical crimes, and the Lancet commission report on medicine, Nazism, and the Holocaust.","authors":"Shmuel P Reis, Hedy S Wald","doi":"10.1186/s13584-024-00610-2","DOIUrl":"10.1186/s13584-024-00610-2","url":null,"abstract":"","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"13 1","pages":"25"},"PeriodicalIF":4.5,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11077749/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140877577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring pre-MRI imaging tests: patient survey reveals potential implications for healthcare efficiency in Israel. 探索核磁共振成像前的成像检查:患者调查揭示了对以色列医疗效率的潜在影响。
IF 3.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-04-01 DOI: 10.1186/s13584-024-00593-0
Arielle Kaim, Clara Singer, Lucia Bergovoy-Yellin, Osnat Luxenburg, Sharona Vaknin, Noga Boldor, Rachel Wilf-Miron, Vicki Myers

Background: Medical imaging tests are vital in healthcare but can be costly, impacting national health expenditures. Magnetic resonance imaging (MRI) is a crucial diagnostic tool for assessing medical conditions. However, the rising demand for MRI scans has frequently strained available resources. This study aimed to estimate the prevalence of different imaging tests in individuals who eventually had an MRI, in the Israeli public health system.

Methods: An online survey of patient experience of scheduling an MRI was conducted in January-February 2023, among 557 Israeli adults, representing all four health maintenance organizations (HMOs). All participants had undergone an MRI in the public health system within the past year.

Results: Results showed that 60% of participants underwent other imaging tests before their MRI scan. Of those, computed tomography (CT) scans (43%), X-rays (39%), and ultrasounds (32%) were the most common additional imaging procedures. In addition, of the 60% of participants, 23% had undergone more than one prior imaging examination.

Conclusions: These findings highlight the high prevalence of preliminary imaging tests prior to MRI, with many patients undergoing multiple tests for the same problem. The health system may need to evaluate whether current clinical guidelines defining the use of various imaging tests are cost-effective.

背景:医学影像检查在医疗保健中至关重要,但成本高昂,影响国民健康支出。磁共振成像(MRI)是评估医疗状况的重要诊断工具。然而,核磁共振成像扫描需求的不断增长常常使可用资源捉襟见肘。本研究旨在估算以色列公共卫生系统中最终接受核磁共振成像检查的患者接受不同成像检查的比例:方法:2023 年 1 月至 2 月,我们对 557 名以色列成年人进行了核磁共振成像检查预约体验在线调查,调查对象包括所有四家健康维护组织 (HMO)。所有参与者在过去一年内均在公共医疗系统接受过核磁共振成像检查:结果显示,60%的参与者在接受核磁共振成像扫描前接受了其他成像检查。其中,计算机断层扫描(CT)(43%)、X 光(39%)和超声波(32%)是最常见的附加成像程序。此外,在 60% 的参与者中,23% 的人之前接受过一次以上的成像检查:这些研究结果突显了在进行核磁共振成像之前进行初步成像检查的普遍性,许多患者因同一问题接受了多次检查。医疗系统可能需要评估目前界定使用各种成像检查的临床指南是否具有成本效益。
{"title":"Exploring pre-MRI imaging tests: patient survey reveals potential implications for healthcare efficiency in Israel.","authors":"Arielle Kaim, Clara Singer, Lucia Bergovoy-Yellin, Osnat Luxenburg, Sharona Vaknin, Noga Boldor, Rachel Wilf-Miron, Vicki Myers","doi":"10.1186/s13584-024-00593-0","DOIUrl":"10.1186/s13584-024-00593-0","url":null,"abstract":"<p><strong>Background: </strong>Medical imaging tests are vital in healthcare but can be costly, impacting national health expenditures. Magnetic resonance imaging (MRI) is a crucial diagnostic tool for assessing medical conditions. However, the rising demand for MRI scans has frequently strained available resources. This study aimed to estimate the prevalence of different imaging tests in individuals who eventually had an MRI, in the Israeli public health system.</p><p><strong>Methods: </strong>An online survey of patient experience of scheduling an MRI was conducted in January-February 2023, among 557 Israeli adults, representing all four health maintenance organizations (HMOs). All participants had undergone an MRI in the public health system within the past year.</p><p><strong>Results: </strong>Results showed that 60% of participants underwent other imaging tests before their MRI scan. Of those, computed tomography (CT) scans (43%), X-rays (39%), and ultrasounds (32%) were the most common additional imaging procedures. In addition, of the 60% of participants, 23% had undergone more than one prior imaging examination.</p><p><strong>Conclusions: </strong>These findings highlight the high prevalence of preliminary imaging tests prior to MRI, with many patients undergoing multiple tests for the same problem. The health system may need to evaluate whether current clinical guidelines defining the use of various imaging tests are cost-effective.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"13 1","pages":"7"},"PeriodicalIF":3.5,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10983758/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140332173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug shortages in Israel, revisited: a bitter pill to swallow. 以色列药品短缺问题再探:难以下咽的苦果。
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-03-18 DOI: 10.1186/s13584-024-00600-4
Eyal Schwartzberg, Eli Marom, Alla Vishkautzan, Einat Gorelik, Segev Shani

Background: In 2017, we published an article addressing drug shortages (DS) in Israel, exploring regulatory perspectives, challenges, and potential solutions. Since then, DS remain a significant concern for patients, healthcare providers, and policymakers globally. In this updated article, we revisit the topic, providing new insights, data, and analysis on the current DS landscape in Israel, efforts to mitigate them, and propose strategies to combat this escalating issue.

Methods: We conducted a comprehensive search of the Israeli Ministry of Health (MOH) DS database, spanning from 2014 to the present. We extracted DS numbers and their reasons. Further searches on the Israeli MOH website, pharmaceutical division archives, and the internet yielded official MOH publications and correspondence regarding regulatory responses to DS from 2017 onwards. Additionally, two specific cases of DS were examined to analyze their handling. Recent activities and publications from the Israeli MOH aimed at reducing DS were also reviewed.

Results: Between 2014 and 2022, DS surged 2.66-fold. Total DS were 3228; 672 due to commercial reasons, and 2556 to operational reasons (20.5% and 79.5% respectively). The average duration of intermittent DS increased 1.56-fold, from 85 to 133 days. Manufacturers informed the MOH 22 days prior to actual shortage on average. Analyzing 2022's DS (640) by ATC groups, prominent categories included nervous system drugs (18%), drugs acting on the alimentary tract and metabolism (14%), and dermatologicals (11%). Operational DS in 2022 (n = 564) were primarily due to stock delivery delays (38%), stock over-utilization (12%), and raw material shortages (9%). Sixteen official MOH publications on DS were identified from 2017 onwards. Moreover, two high-impact DS case studies were examined.

Conclusion: Despite routine monitoring by the Israeli MOH and updating the DS policy throughout this period, DS persist, intensifying annually and posing serious health risks. This trend mirrors international patterns, affecting countries globally. In Israel's uniquely structured healthcare system, with its swift stakeholder cooperation and implementation capabilities, more effective DS management is conceivable. We propose ten universally applicable rules to address DS challenges.

背景:2017 年,我们发表了一篇关于以色列药物短缺(DS)的文章,探讨了监管视角、挑战和潜在解决方案。从那时起,药物短缺仍然是全球患者、医疗服务提供者和政策制定者关注的一个重要问题。在这篇更新的文章中,我们重新审视了这一话题,提供了有关以色列目前DS状况的新见解、数据和分析,以及为缓解DS所做的努力,并提出了应对这一不断升级的问题的策略:我们对以色列卫生部(MOH)的 DS 数据库进行了全面搜索,时间跨度从 2014 年至今。我们提取了 DS 数量及其原因。通过进一步搜索以色列卫生部网站、制药部门档案和互联网,我们获得了卫生部自 2017 年以来有关 DS 监管对策的官方出版物和信函。此外,还研究了两个具体的 DS 案例,以分析其处理情况。此外,还审查了以色列卫生部近期旨在减少 DS 的活动和出版物:结果:2014 年至 2022 年间,DS 激增了 2.66 倍。DS 总数为 3228 个;其中 672 个是由于商业原因,2556 个是由于操作原因(分别占 20.5%和 79.5%)。间歇性 DS 的平均持续时间增加了 1.56 倍,从 85 天增加到 133 天。制造商平均在实际短缺前 22 天通知卫生部。按ATC类别分析2022年的DS(640种),主要类别包括神经系统药物(18%)、作用于消化道和新陈代谢的药物(14%)以及皮肤病药物(11%)。2022 年运行中的 DS(564 人)主要是由于库存交付延迟(38%)、库存过度使用(12%)和原材料短缺(9%)造成的。自 2017 年起,共发现 16 份有关 DS 的卫生部官方出版物。此外,还研究了两个影响较大的 DS 案例:尽管以色列卫生部在此期间进行了例行监测并更新了 DS 政策,但 DS 依然存在,并且每年都在加剧,造成了严重的健康风险。这一趋势反映了国际模式,影响着全球各国。以色列的医疗保健系统结构独特,利益相关者合作迅速,执行能力强,因此可以对 DS 进行更有效的管理。我们提出了十条普遍适用的规则,以应对 DS 挑战。
{"title":"Drug shortages in Israel, revisited: a bitter pill to swallow.","authors":"Eyal Schwartzberg, Eli Marom, Alla Vishkautzan, Einat Gorelik, Segev Shani","doi":"10.1186/s13584-024-00600-4","DOIUrl":"10.1186/s13584-024-00600-4","url":null,"abstract":"<p><strong>Background: </strong>In 2017, we published an article addressing drug shortages (DS) in Israel, exploring regulatory perspectives, challenges, and potential solutions. Since then, DS remain a significant concern for patients, healthcare providers, and policymakers globally. In this updated article, we revisit the topic, providing new insights, data, and analysis on the current DS landscape in Israel, efforts to mitigate them, and propose strategies to combat this escalating issue.</p><p><strong>Methods: </strong>We conducted a comprehensive search of the Israeli Ministry of Health (MOH) DS database, spanning from 2014 to the present. We extracted DS numbers and their reasons. Further searches on the Israeli MOH website, pharmaceutical division archives, and the internet yielded official MOH publications and correspondence regarding regulatory responses to DS from 2017 onwards. Additionally, two specific cases of DS were examined to analyze their handling. Recent activities and publications from the Israeli MOH aimed at reducing DS were also reviewed.</p><p><strong>Results: </strong>Between 2014 and 2022, DS surged 2.66-fold. Total DS were 3228; 672 due to commercial reasons, and 2556 to operational reasons (20.5% and 79.5% respectively). The average duration of intermittent DS increased 1.56-fold, from 85 to 133 days. Manufacturers informed the MOH 22 days prior to actual shortage on average. Analyzing 2022's DS (640) by ATC groups, prominent categories included nervous system drugs (18%), drugs acting on the alimentary tract and metabolism (14%), and dermatologicals (11%). Operational DS in 2022 (n = 564) were primarily due to stock delivery delays (38%), stock over-utilization (12%), and raw material shortages (9%). Sixteen official MOH publications on DS were identified from 2017 onwards. Moreover, two high-impact DS case studies were examined.</p><p><strong>Conclusion: </strong>Despite routine monitoring by the Israeli MOH and updating the DS policy throughout this period, DS persist, intensifying annually and posing serious health risks. This trend mirrors international patterns, affecting countries globally. In Israel's uniquely structured healthcare system, with its swift stakeholder cooperation and implementation capabilities, more effective DS management is conceivable. We propose ten universally applicable rules to address DS challenges.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"13 1","pages":"14"},"PeriodicalIF":4.5,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10946123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140159263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disclosure following a medical error: lessons learned from a national initiative of workshops with patients, healthcare teams, and executives. 医疗事故发生后的信息披露:从与患者、医疗团队和管理人员举办的全国性研讨会中汲取的经验教训。
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-03-11 DOI: 10.1186/s13584-024-00599-8
Adi Finkelstein, Mayer Brezis, Amiad Taub, Dana Arad

Background: Despite the increase in disclosures of medical errors, transparency remains a challenge. Recognized barriers include shame, fear of litigation, disciplinary actions, and loss of patient trust. In 2018, the Israeli Ministry of Health initiated a series of workshops about disclosure of medical errors. The workshops involved medical center executives, healthcare providers, patients, and family members of patients who had previously been harmed by a medical error. This study presents the lessons learned about perceived challenges in disclosure of errors in 15 such workshops.

Methods: Data collection included participant observations in 15 workshops, full audio recordings of all of the workshops, and documentation of detailed field notes. Analysis was performed under thematic analysis guidelines.

Results: We identified four main themes: "Providers agree on the value of disclosure of a medical error to the patient"; "Emotional challenges of disclosure of medical error to patients"; "The medico-legal discourse challenges transparency"; and "Providers and patients call for a change in the culture regarding disclosure of medical errors". Participant observations indicated that the presence of a patient who had experienced a tragedy in another hospital, and who was willing to share it created an intimate atmosphere that enabled an open conversation between parties.

Conclusion: The study shows the moral, human, and educational values of open discourse in a protective setting after the occurrence of a medical error. We believe that workshops like these may help foster a culture of institutional disclosure following medical errors. We recommend that the Ministry of Health extend such workshops to all healthcare facilities, establish guidelines and mandate training for skills in disclosure for all providers.

背景:尽管披露医疗事故的情况越来越多,但透明度仍然是一项挑战。公认的障碍包括羞耻感、对诉讼的恐惧、纪律处分以及失去患者的信任。2018 年,以色列卫生部发起了一系列关于披露医疗事故的研讨会。参与研讨会的有医疗中心管理人员、医疗服务提供者、患者以及曾受到医疗事故伤害的患者家属。本研究介绍了在 15 次此类研讨会上所汲取的有关披露医疗事故所面临挑战的经验教训:数据收集包括 15 场研讨会的参与者观察、所有研讨会的完整录音以及详细的现场记录。结果:我们确定了四个主题:"在工作坊中,我们发现了哪些挑战?我们确定了四大主题:"医疗服务提供者认同向患者披露医疗事故的价值";"向患者披露医疗事故的情感挑战";"医学法律话语挑战透明度";以及 "医疗服务提供者和患者呼吁改变披露医疗事故的文化"。参与者的观察表明,一位曾在另一家医院经历过悲剧并愿意分享的患者的存在营造了一种亲密的氛围,使双方能够进行坦诚的对话:这项研究表明,在医疗事故发生后的保护性环境中进行公开对话具有道德、人文和教育价值。我们相信,类似的研讨会可能有助于培养医疗事故发生后的机构披露文化。我们建议卫生部将此类研讨会推广到所有医疗机构,制定指导方针,并强制要求对所有医疗服务提供者进行披露技能培训。
{"title":"Disclosure following a medical error: lessons learned from a national initiative of workshops with patients, healthcare teams, and executives.","authors":"Adi Finkelstein, Mayer Brezis, Amiad Taub, Dana Arad","doi":"10.1186/s13584-024-00599-8","DOIUrl":"10.1186/s13584-024-00599-8","url":null,"abstract":"<p><strong>Background: </strong>Despite the increase in disclosures of medical errors, transparency remains a challenge. Recognized barriers include shame, fear of litigation, disciplinary actions, and loss of patient trust. In 2018, the Israeli Ministry of Health initiated a series of workshops about disclosure of medical errors. The workshops involved medical center executives, healthcare providers, patients, and family members of patients who had previously been harmed by a medical error. This study presents the lessons learned about perceived challenges in disclosure of errors in 15 such workshops.</p><p><strong>Methods: </strong>Data collection included participant observations in 15 workshops, full audio recordings of all of the workshops, and documentation of detailed field notes. Analysis was performed under thematic analysis guidelines.</p><p><strong>Results: </strong>We identified four main themes: \"Providers agree on the value of disclosure of a medical error to the patient\"; \"Emotional challenges of disclosure of medical error to patients\"; \"The medico-legal discourse challenges transparency\"; and \"Providers and patients call for a change in the culture regarding disclosure of medical errors\". Participant observations indicated that the presence of a patient who had experienced a tragedy in another hospital, and who was willing to share it created an intimate atmosphere that enabled an open conversation between parties.</p><p><strong>Conclusion: </strong>The study shows the moral, human, and educational values of open discourse in a protective setting after the occurrence of a medical error. We believe that workshops like these may help foster a culture of institutional disclosure following medical errors. We recommend that the Ministry of Health extend such workshops to all healthcare facilities, establish guidelines and mandate training for skills in disclosure for all providers.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"13 1","pages":"13"},"PeriodicalIF":4.5,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10926562/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140094802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of prescription opioids in Israel and socio-economic correlations between 2010 and 2020. 2010 至 2020 年以色列处方类阿片的使用情况及社会经济相关性。
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-03-07 DOI: 10.1186/s13584-024-00598-9
Limor Adler, Bar Cohen, Shirley Shapiro Ben Daviv, Ori Liran, Daniella Rahamim-Cohen, Afif Nakhleh, Arnon Shahar, Joseph Azuri

Background: The use of opioids has increased dramatically over the past several years in Israel. The aim of this study was to explore the trends of opioid consumption in Israel over a decade (2010-2020) stratified by socioeconomic status (SES), residence in the periphery, and ethnic background.

Methods: This cross-sectional study included all adult Maccabi Healthcare Services (MHS) patients who filled at least one prescription for opioids during the past decade. In order to standardize dosages and compare different opioid medications, we used the Morphine Milligram Equivalent (MME) conversion factor. We performed The Mann-Kendall test with autocorrelation correction to assess each trend. We then checked the differences between the trends with the Mann-Whitney test (for periphery) and the Kruskal Wallis (for SES and ethnic background).

Results: Between the years 2010-2020, 261,270 MHS members met the study's inclusion criteria. The proportions of opioids consumption were 23.9/1000 patients in 2010 and 27.6/1000 patients in 2020, representing a 15% increase. The average daily consumption of opioids was 4.6 and 10.5 MME in 2010 and 2020, respectively, an increase of 227%. The daily MME during 2020 was higher for residents of the periphery compared to non-periphery residents (daily MME of 14.0 compared to 10.1, respectively). Average daily MME increased gradually during the study period for all levels of SES; the values were highest for the low SES group and the lowest for the high SES group (daily MME in 2020 for the lowest, middle, and high SES groups were 15.2 vs. 11.8 vs. 6.7 respectively).

Conclusions: This study highlights that the primary concern in the increase of opioid use is the increasing dosages. The increase in the number of patients using opioids is also significant but to a minor extent. These phenomena disproportionately impact vulnerable populations. Education programs should be offered to physicians regarding the possible harms of long-term use of opioids. These programs should emphasize the risk factors associated with the development of opioid use disorder (OUD) and the caution needed when increasing dosages or switching to higher-potency drugs. Pain clinics and centers for rehabilitation for patients with chronic pain or OUD should be available, not only in central areas but also in the periphery of the country. These clinics and centers should use a holistic approach and a multidisciplinary team that includes specialists in pain and addiction. They should be financially accessible for patients from low SES group and provide solutions in multiple languages.

背景:在过去几年中,阿片类药物的使用量在以色列急剧增加。本研究的目的是探讨十年来(2010-2020 年)以色列阿片类药物的消费趋势,并按社会经济地位(SES)、外围居住地和种族背景进行分层:这项横断面研究包括过去十年间至少开过一次阿片类药物处方的所有马卡比医疗保健服务机构(MHS)成年患者。为了使剂量标准化并比较不同的阿片类药物,我们使用了吗啡毫克当量(MME)换算系数。我们进行了带有自相关校正的 Mann-Kendall 检验,以评估每种趋势。然后,我们使用 Mann-Whitney 检验(针对周边地区)和 Kruskal Wallis 检验(针对社会经济地位和种族背景)来检查趋势之间的差异:2010-2020 年间,261,270 名医疗健康计划成员符合研究的纳入标准。阿片类药物的消费比例2010年为23.9/1000,2020年为27.6/1000,增长了15%。2010年和2020年阿片类药物的日均消耗量分别为4.6毫克和10.5毫克,增长了227%。与非周边地区居民相比,2020年周边地区居民的日均阿片类药物消费量更高(分别为14.0毫克和10.1毫克)。在研究期间,所有社会经济地位水平的居民的日均市容市貌逐渐增加;低社会经济地位组的数值最高,高社会经济地位组的数值最低(2020 年,最低、中、高社会经济地位组的日均市容市貌分别为 15.2 vs. 11.8 vs. 6.7):本研究强调,阿片类药物使用量增加的主要原因是剂量的增加。使用阿片类药物的患者人数增加也很重要,但程度较轻。这些现象对弱势群体的影响尤为严重。应向医生提供有关长期使用阿片类药物可能造成危害的教育计划。这些计划应强调与阿片类药物使用障碍(OUD)发展相关的风险因素,以及在增加剂量或改用高效力药物时需要谨慎。不仅在中心地区,而且在国家周边地区也应为慢性疼痛或 OUD 患者提供疼痛诊所和康复中心。这些诊所和中心应采用综合方法,并由疼痛和成瘾方面的专家组成多学科团队。这些诊所和中心应为社会经济地位低下的患者提供经济援助,并以多种语言提供解决方案。
{"title":"Use of prescription opioids in Israel and socio-economic correlations between 2010 and 2020.","authors":"Limor Adler, Bar Cohen, Shirley Shapiro Ben Daviv, Ori Liran, Daniella Rahamim-Cohen, Afif Nakhleh, Arnon Shahar, Joseph Azuri","doi":"10.1186/s13584-024-00598-9","DOIUrl":"10.1186/s13584-024-00598-9","url":null,"abstract":"<p><strong>Background: </strong>The use of opioids has increased dramatically over the past several years in Israel. The aim of this study was to explore the trends of opioid consumption in Israel over a decade (2010-2020) stratified by socioeconomic status (SES), residence in the periphery, and ethnic background.</p><p><strong>Methods: </strong>This cross-sectional study included all adult Maccabi Healthcare Services (MHS) patients who filled at least one prescription for opioids during the past decade. In order to standardize dosages and compare different opioid medications, we used the Morphine Milligram Equivalent (MME) conversion factor. We performed The Mann-Kendall test with autocorrelation correction to assess each trend. We then checked the differences between the trends with the Mann-Whitney test (for periphery) and the Kruskal Wallis (for SES and ethnic background).</p><p><strong>Results: </strong>Between the years 2010-2020, 261,270 MHS members met the study's inclusion criteria. The proportions of opioids consumption were 23.9/1000 patients in 2010 and 27.6/1000 patients in 2020, representing a 15% increase. The average daily consumption of opioids was 4.6 and 10.5 MME in 2010 and 2020, respectively, an increase of 227%. The daily MME during 2020 was higher for residents of the periphery compared to non-periphery residents (daily MME of 14.0 compared to 10.1, respectively). Average daily MME increased gradually during the study period for all levels of SES; the values were highest for the low SES group and the lowest for the high SES group (daily MME in 2020 for the lowest, middle, and high SES groups were 15.2 vs. 11.8 vs. 6.7 respectively).</p><p><strong>Conclusions: </strong>This study highlights that the primary concern in the increase of opioid use is the increasing dosages. The increase in the number of patients using opioids is also significant but to a minor extent. These phenomena disproportionately impact vulnerable populations. Education programs should be offered to physicians regarding the possible harms of long-term use of opioids. These programs should emphasize the risk factors associated with the development of opioid use disorder (OUD) and the caution needed when increasing dosages or switching to higher-potency drugs. Pain clinics and centers for rehabilitation for patients with chronic pain or OUD should be available, not only in central areas but also in the periphery of the country. These clinics and centers should use a holistic approach and a multidisciplinary team that includes specialists in pain and addiction. They should be financially accessible for patients from low SES group and provide solutions in multiple languages.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"13 1","pages":"12"},"PeriodicalIF":4.5,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10918956/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Israeli health system's rapid responses during the COVID-19 pandemic. 以色列卫生系统在 COVID-19 大流行期间的快速反应。
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-03-04 DOI: 10.1186/s13584-024-00596-x
Bruce Rosen, Michael Hartal, Ruth Waitzberg
<p><strong>Background: </strong>The COVID-19 pandemic posed numerous challenges to health systems around the world. In addressing many of those challenges, Israel responded quite rapidly. While quick action is not an end in it itself, it can be important in responding to disease outbreaks. Some of Israel's rapid responses to the pandemic contributed significantly to population health and provided important learning opportunities for other countries.</p><p><strong>Main body: </strong>Some of the most prominent Israeli rapid responses were related to vaccination. Israel led the world in the pace of its initial vaccine rollout, and it was also the first country to approve and administer booster vaccines to broad segments of the population. In addition, Israeli scholars published a series of timely reports analyzing vaccination impact, which informed policy in Israel and other countries. Israel was a rapid responder in additional areas of public health. These include the partial closure of its borders, the adoption of physical distancing measures, the use of digital surveillance technology for contact tracing, the use of wastewater surveillance to monitor viral spread, and the use of vaccine certificates ("green passes") to facilitate a return to routine in the face of the ongoing pandemic. Many factors contributed to Israel's capacity to repeatedly respond rapidly to a broad array of COVID-19 challenges. These include a national health insurance system that promotes public-private coordination, a system of universal electronic health records, a high level of emergency preparedness, a culture of focusing on goal attainment, a culture of innovation, and the presence of a strong scientific community which is highly connected internationally. In addition, some of the rapid responses (e.g., the rapid initial vaccination rollout) facilitated rapid responses in related areas (e.g., the analysis of vaccination impact, the administration of boosters, and the adoption of green passes). While rapid response can contribute to population health and economic resilience, it can also entail costs, risks, and limitations. These include making decisions and acting before all the relevant information is available; deciding without sufficient consideration of the full range of possible effects, costs, and benefits; not providing enough opportunities for the involvement of relevant groups in the decision-making process; and depleting non-renewable resources.</p><p><strong>Conclusions: </strong>Based on our findings, we encourage leaders in the Israeli government to ensure that its emergency response system will continue to have the capacity to respond rapidly to large-scale challenges, whether of a military or civilian nature. At the same time, the emergency response systems should develop mechanisms to include more stakeholders in the fast-paced decision-making process and should improve communication with the public. In addition, they should put into place mechanisms
背景:COVID-19 大流行给世界各地的卫生系统带来了众多挑战。在应对其中许多挑战时,以色列的反应相当迅速。虽然快速行动本身并不是目的,但在应对疾病爆发时却非常重要。以色列对大流行病的一些快速反应极大地促进了人口健康,并为其他国家提供了重要的学习机会:以色列最突出的一些快速反应与疫苗接种有关。以色列在最初推出疫苗的速度上走在了世界前列,它也是第一个批准并为广大人群接种强化疫苗的国家。此外,以色列学者及时发表了一系列分析疫苗接种影响的报告,为以色列和其他国家的政策提供了参考。以色列在其他公共卫生领域也迅速做出反应。这些措施包括部分关闭边界、采取物理隔离措施、使用数字监控技术追踪接触者、使用废水监控来监测病毒传播,以及使用疫苗证书("绿色通行证")来帮助人们在面对持续的大流行时恢复正常生活。以色列之所以有能力多次快速应对 COVID-19 的各种挑战,有许多因素。这些因素包括:促进公私协调的国家医疗保险制度、普及电子健康记录系统、高度的应急准备、注重实现目标的文化、创新文化以及与国际联系紧密的强大科学界。此外,一些快速反应(如快速启动疫苗接种)促进了相关领域的快速反应(如分析疫苗接种的影响、实施强化免疫以及采用绿色通行证)。虽然快速反应可促进人口健康和经济恢复能力,但也会带来成本、风险和限制。这些因素包括:在获得所有相关信息之前就做出决定并采取行动;在做出决定时没有充分考虑可能产生的各种影响、成本和效益;没有为相关群体参与决策过程提供足够的机会;以及耗尽不可再生资源:根据我们的研究结果,我们鼓励以色列政府领导人确保其应急系统将继续有能力快速应对大规模挑战,无论是军事性质还是民事性质的挑战。与此同时,应急系统应建立机制,让更多利益相关方参与快速决策过程,并改善与公众的沟通。此外,应急系统还应建立机制,及时重新考虑、调整并在必要时推翻那些在做出决定时虽然合理,但根据随后的事态发展和证据证明并不明智的决定。这些机制可能涉及政府的任何或所有部门,以及公众、新闻界和专业组织。我们的研究结果对其他国家的医疗系统领导者也有借鉴意义。以色列的经验可以帮助他们确定在非紧急情况下需要发展的关键能力,从而在紧急情况下更迅速地做出反应。最后,其他国家的卫生系统领导者可以关注以色列对未来全球卫生突发事件的快速反应,并在本国采取选定的行动。
{"title":"The Israeli health system's rapid responses during the COVID-19 pandemic.","authors":"Bruce Rosen, Michael Hartal, Ruth Waitzberg","doi":"10.1186/s13584-024-00596-x","DOIUrl":"10.1186/s13584-024-00596-x","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The COVID-19 pandemic posed numerous challenges to health systems around the world. In addressing many of those challenges, Israel responded quite rapidly. While quick action is not an end in it itself, it can be important in responding to disease outbreaks. Some of Israel's rapid responses to the pandemic contributed significantly to population health and provided important learning opportunities for other countries.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main body: &lt;/strong&gt;Some of the most prominent Israeli rapid responses were related to vaccination. Israel led the world in the pace of its initial vaccine rollout, and it was also the first country to approve and administer booster vaccines to broad segments of the population. In addition, Israeli scholars published a series of timely reports analyzing vaccination impact, which informed policy in Israel and other countries. Israel was a rapid responder in additional areas of public health. These include the partial closure of its borders, the adoption of physical distancing measures, the use of digital surveillance technology for contact tracing, the use of wastewater surveillance to monitor viral spread, and the use of vaccine certificates (\"green passes\") to facilitate a return to routine in the face of the ongoing pandemic. Many factors contributed to Israel's capacity to repeatedly respond rapidly to a broad array of COVID-19 challenges. These include a national health insurance system that promotes public-private coordination, a system of universal electronic health records, a high level of emergency preparedness, a culture of focusing on goal attainment, a culture of innovation, and the presence of a strong scientific community which is highly connected internationally. In addition, some of the rapid responses (e.g., the rapid initial vaccination rollout) facilitated rapid responses in related areas (e.g., the analysis of vaccination impact, the administration of boosters, and the adoption of green passes). While rapid response can contribute to population health and economic resilience, it can also entail costs, risks, and limitations. These include making decisions and acting before all the relevant information is available; deciding without sufficient consideration of the full range of possible effects, costs, and benefits; not providing enough opportunities for the involvement of relevant groups in the decision-making process; and depleting non-renewable resources.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Based on our findings, we encourage leaders in the Israeli government to ensure that its emergency response system will continue to have the capacity to respond rapidly to large-scale challenges, whether of a military or civilian nature. At the same time, the emergency response systems should develop mechanisms to include more stakeholders in the fast-paced decision-making process and should improve communication with the public. In addition, they should put into place mechanisms ","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"13 1","pages":"11"},"PeriodicalIF":4.5,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910866/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140029269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"When everyone is responsible, no one takes responsibility": exploring pediatric physiotherapy services in Israel. "人人有责,无人负责":探讨以色列的儿科物理治疗服务。
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-02-27 DOI: 10.1186/s13584-024-00597-w
Nilly Waiserberg, Tuvia Horev, Paula Feder-Bubis

Background: According to Israel's National Health Insurance Law (1994), the Ministry of Health is responsible for the provision of health services in the country including physiotherapy services; moreover, the Special Education Law (1988), stipulates that physiotherapy services for children with motor disabilities, as well as other allied health services, are provided by the Ministry of Education in educational settings. Thus, children with motor disabilities are entitled PT services under two different laws by two different ministries.

Method: To describe the physiotherapy services for children with motor disabilities and examine how policymakers view these services, we conducted a qualitative study including in-depth semi-structured interviews with 10 policymakers from the Ministry of Health and the Ministry of Education, and the national directors of physiotherapy services from three of the four health maintenance organizations in Israel.

Results: Study results indicate that there is an array of physiotherapy services and providers. Despite the regulation of these services for children with motor disabilities, uncertainty and lack of knowledge were found about various issues. Therefore, the thematic analysis was structured around four descriptive questions: Where do the children receive physiotherapy? Who is eligible for physiotherapy treatment and who receives treatment? What interventions do children with motor disabilities receive? Who provides therapy for children with motor disabilities?

Conclusions: Policymakers are dubious regarding the provision of these services, questioning whether children with motor disabilities receive physiotherapy services according to their needs. In addition, the abundance of suppliers does not necessarily improve the quality of services provided to children with motor disabilities, which may ultimately harm their developmental potential.

背景:根据以色列的《国家医疗保险法》(1994 年),卫生部负责提供包括物理治疗服务在内的国家医疗服务;此外,《特殊教育法》(1988 年)规定,运动残疾儿童的物理治疗服务以及其他相关医疗服务由教育部在教育环境中提供。因此,根据两部不同的法律,运动残疾儿童有权获得由两个不同部委提供的物理治疗服务:为了描述运动残疾儿童的物理治疗服务并研究政策制定者如何看待这些服务,我们进行了一项定性研究,包括对卫生部和教育部的 10 名政策制定者以及以色列四家健康维护组织中三家的全国物理治疗服务主任进行深入的半结构式访谈:研究结果表明,物理治疗服务和提供者种类繁多。尽管对运动障碍儿童的这些服务进行了规范,但仍发现在各种问题上存在不确定性并缺乏相关知识。因此,专题分析围绕四个描述性问题展开:儿童在哪里接受物理治疗?谁有资格接受物理治疗?运动残疾儿童接受哪些干预?谁为运动残疾儿童提供治疗?政策制定者对这些服务的提供存在疑虑,质疑运动残疾儿童是否根据自己的需要接受物理治疗服务。此外,供应商的增多并不一定能提高为运动残疾儿童提供的服务质量,最终可能会损害他们的发展潜力。
{"title":"\"When everyone is responsible, no one takes responsibility\": exploring pediatric physiotherapy services in Israel.","authors":"Nilly Waiserberg, Tuvia Horev, Paula Feder-Bubis","doi":"10.1186/s13584-024-00597-w","DOIUrl":"10.1186/s13584-024-00597-w","url":null,"abstract":"<p><strong>Background: </strong>According to Israel's National Health Insurance Law (1994), the Ministry of Health is responsible for the provision of health services in the country including physiotherapy services; moreover, the Special Education Law (1988), stipulates that physiotherapy services for children with motor disabilities, as well as other allied health services, are provided by the Ministry of Education in educational settings. Thus, children with motor disabilities are entitled PT services under two different laws by two different ministries.</p><p><strong>Method: </strong>To describe the physiotherapy services for children with motor disabilities and examine how policymakers view these services, we conducted a qualitative study including in-depth semi-structured interviews with 10 policymakers from the Ministry of Health and the Ministry of Education, and the national directors of physiotherapy services from three of the four health maintenance organizations in Israel.</p><p><strong>Results: </strong>Study results indicate that there is an array of physiotherapy services and providers. Despite the regulation of these services for children with motor disabilities, uncertainty and lack of knowledge were found about various issues. Therefore, the thematic analysis was structured around four descriptive questions: Where do the children receive physiotherapy? Who is eligible for physiotherapy treatment and who receives treatment? What interventions do children with motor disabilities receive? Who provides therapy for children with motor disabilities?</p><p><strong>Conclusions: </strong>Policymakers are dubious regarding the provision of these services, questioning whether children with motor disabilities receive physiotherapy services according to their needs. In addition, the abundance of suppliers does not necessarily improve the quality of services provided to children with motor disabilities, which may ultimately harm their developmental potential.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"13 1","pages":"10"},"PeriodicalIF":4.5,"publicationDate":"2024-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900823/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139984170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Israel Journal of Health Policy Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1